- Home
- PCYO vs ABEO Comparison
PCYO vs ABEO Comparison
Compare PCYO & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCYO
- ABEO
- Stock Information
- Founded
- PCYO 1976
- ABEO 1974
- Country
- PCYO United States
- ABEO United States
- Employees
- PCYO N/A
- ABEO N/A
- Industry
- PCYO Water Supply
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- PCYO Utilities
- ABEO Health Care
- Exchange
- PCYO Nasdaq
- ABEO Nasdaq
- Market Cap
- PCYO 248.0M
- ABEO 256.9M
- IPO Year
- PCYO N/A
- ABEO 1980
- Fundamental
- Price
- PCYO $10.05
- ABEO $5.95
- Analyst Decision
- PCYO
- ABEO Strong Buy
- Analyst Count
- PCYO 0
- ABEO 6
- Target Price
- PCYO N/A
- ABEO $18.00
- AVG Volume (30 Days)
- PCYO 46.4K
- ABEO 1.1M
- Earning Date
- PCYO 07-09-2025
- ABEO 08-11-2025
- Dividend Yield
- PCYO N/A
- ABEO N/A
- EPS Growth
- PCYO 123.89
- ABEO N/A
- EPS
- PCYO 0.56
- ABEO N/A
- Revenue
- PCYO $27,447,000.00
- ABEO N/A
- Revenue This Year
- PCYO N/A
- ABEO N/A
- Revenue Next Year
- PCYO N/A
- ABEO $322.37
- P/E Ratio
- PCYO $18.00
- ABEO N/A
- Revenue Growth
- PCYO 40.36
- ABEO N/A
- 52 Week Low
- PCYO $9.49
- ABEO $3.93
- 52 Week High
- PCYO $14.63
- ABEO $7.32
- Technical
- Relative Strength Index (RSI)
- PCYO 42.81
- ABEO 51.37
- Support Level
- PCYO $10.00
- ABEO $5.66
- Resistance Level
- PCYO $10.96
- ABEO $5.99
- Average True Range (ATR)
- PCYO 0.34
- ABEO 0.24
- MACD
- PCYO -0.07
- ABEO 0.01
- Stochastic Oscillator
- PCYO 14.66
- ABEO 74.19
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.